[Use of antikinin preparations as pathogenetic agents in the overall therapy of tuberculosis].
D000614:Aminocaproates / Q000627:therapeutic use; D000818:Animals; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D006168:Guinea Pigs; D006801:Humans; D007213:Indomethacin / Q000627:therapeutic use; D007705:Kinins / Q000037:antagonists & inhibitors*; D011480:Protease Inhibitors; D011727:Pyridinolcarbamate / Q000627:therapeutic use; D011817:Rabbits; D013997:Time Factors; D014376:Tuberculosis / Q000188:drug therapy*; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy
D000614:Aminocaproates; D004791:Enzyme Inhibitors; D007705:Kinins; D011480:Protease Inhibitors; D011727:Pyridinolcarbamate; D007213:Indomethacin
Primenenie antikininovykh preparatov kak patogeneticheskikh sredstv v kompleksnoĭ terapii tuberkuleza.